Flower to Edibles and Beverages: The Shift, in Numbers

Photo by Kindel Media via Pexels.

Start with the number that gets buried every time someone declares flower dead: $9.6 billion. That's what flower generated in tracked US sales over the twelve months ending June 2026, according to Headset's point-of-sale data, good for 39.4% of the entire market. Nothing else is close. So no, this isn't a story about flower dying. It's a story about where the growth has actually relocated to -- and the answer is a set of formats that barely existed as retail categories a decade ago.

Here's the marker worth sitting with for a second: on April 20, 2025, pre-rolls outsold flower for the first time ever on cannabis's single biggest sales day of the year. Not close to overtaking it in overall market share -- flower still dwarfs pre-rolls on the full-year numbers -- but on the one day when demand spikes hardest and buying habits get revealed at their most unfiltered, pre-rolls won. That's a symbolic crossing point, not a verdict, but it's the kind of data point that tends to look obvious in hindsight five years later.

The real momentum, though, is sitting in formats that didn't have meaningful shelf space a decade ago: infused pre-rolls, low-dose edibles, THC beverages. These aren't niche experiments anymore -- they're the fastest-growing lines in the category-level data, and they're growing for identifiable, mechanical reasons rather than vague shifts in taste. And looming over all of it is a federal hemp policy change taking effect in November 2026 that could reshape the beverage category just as it's finding its footing -- a regulatory cliff that's dated, real, and still unresolved.

Flower Still Wins on Volume, Not on Growth

Pre-rolls and beverages led US cannabis category growth with double-digit year-over-year gains, while capsules, topicals, and concentrates declined sharply, with capsules down nearly 25%.

Headset's point-of-sale data for the twelve months ending June 2026 puts flower at $9.6 billion in tracked US sales, or 39.4% of the market -- still the largest single category by a wide margin. If you stopped reading there, you'd conclude flower's position is unassailable. But size and growth are telling two different stories in this dataset, and the growth story is inverted. Pre-rolls grew 10.1% year-over-year, the fastest expansion of any major category tracked, while flower's own growth rate lagged well behind it. The biggest category isn't the one adding share fastest.

The categories losing ground are instructive too. Concentrates fell 7.7%, capsules dropped 24.6%, and topicals declined 13.8%. Look at what those three have in common: they all require more consumer effort or ritual than the alternatives now available. Concentrates need a rig or a specific vape hardware setup. Capsules ask consumers to think about dosing schedules like medication. Topicals occupy a narrow use case that newer formats haven't really displaced so much as bypassed. The pattern reads less like consumers rejecting potency or effect, and more like they're rejecting friction.

Basket penetration data adds a subtler layer that the headline share numbers miss entirely. Flower still shows up in 37.8% of baskets -- still the most common single item people buy. But pre-rolls are right behind at 32.4%, vapor pens at 29.8%, and edibles at 17.1%. What that tells you is that consumers aren't necessarily choosing flower instead of other formats -- they're increasingly buying flower and something else in the same visit. Format diversity per basket is rising even in baskets that still contain flower.

That's the more useful way to read this whole section: it looks like a maturing-market pattern, not a collapse. Mature consumer categories don't usually see their largest incumbent get replaced overnight -- they see incumbents lose growth-rate primacy while newer formats capture the marginal dollar. That's what beer looked like as spirits and RTD cocktails ate into its growth without ever dethroning it in absolute volume for decades. Flower's $9.6 billion isn't going anywhere soon. The interesting money is in what gets added around it.

The Day Pre-Rolls Overtook Flower

Photo by Dad Grass via Pexels.

The 4/20 pre-roll crossover deserves its own unpacking, because the mechanism behind it is more interesting than the headline. A meaningful share of that pre-roll growth is coming specifically from infused pre-rolls -- flower that's been dipped or sprayed with concentrate, kief, or distillate before it's rolled. That subcategory grew 253% between 2021 and 2025, and generated $1.7 billion in revenue over that stretch. That's not incremental growth. That's a subcategory going from a novelty SKU to a genuine pillar of the pre-roll business in four years.

The mechanism is straightforward once you break it down. A standard pre-roll sells convenience -- it removes the grinding and rolling step entirely, which matters more to casual and newer consumers than industry veterans sometimes give it credit for. An infused pre-roll stacks a second value proposition on top of that: it lets a brand sell a premium, higher-margin product without asking the consumer to learn an entirely new format or piece of hardware. You're still smoking a joint. It just happens to hit harder and cost more. That's an unusually low-friction way to trade a consumer up the price ladder.

There's a real precedent for this pattern outside cannabis. Flavored malt beverages and pre-mixed cocktails spent the 2000s and 2010s steadily taking share from spirits-plus-mixer as a category, not by being better in some abstract sense, but by removing steps between purchase and consumption. Once the quality of pre-mixed products caught up to what a reasonably competent home bartender could make, the convenience premium stopped being a tradeoff and started being a clear win. Infused pre-rolls are following a similar arc relative to flower plus rolling papers plus a grinder.

The caveat matters as much as the data point itself, though. April 20th is a heavily promotional, discount-driven day -- brands run their steepest deals of the year on pre-rolls specifically to move volume, and consumer behavior on a single promotional day doesn't necessarily generalize to the other 364. One day's crossover is a leading indicator worth watching closely, not proof that flower's overall decline has arrived. Treat it the way you'd treat a single strong earnings quarter: informative, not conclusive.

Beverages Are Small But Growing Faster Than Everything Else

Photo by Elsa Olofsson via Pexels.

Beverages are still a rounding error next to flower's $9.6 billion, but the growth rate is the fastest of anything BDSA tracks. Q1 2025 beverage sales came in at $54.6 million nationally, up 15% year-over-year. That's a small slice of a large market -- but it's the slice growing fastest, and the state-level breakdown shows exactly where that growth is concentrated.

Michigan beverage sales grew 112% year-over-year. Ohio grew 79%. Those aren't the country's oldest or most saturated markets -- they're newer, more price-competitive markets where consumers are still forming their format habits rather than defending established ones. That's a meaningful distinction: growth this steep in newer markets suggests beverages are winning over consumers who haven't already built brand loyalty to flower or vape pens, rather than converting longtime flower buyers away from what they already know.

California tells a different but equally revealing story. It's a larger, far more mature market, and most major categories there actually declined over the period -- yet beverages grew 8.0% in sales and 14.6% in units. Notice the gap between those two numbers: unit growth outpacing sales growth means the average price per unit fell, and it did -- from $7.52 down to $7.09. Volume is growing faster than revenue, which is exactly the pattern you'd expect from a category that's expanding its customer base by getting more affordable, not one that's expanding because existing buyers are trading up.

That price compression follows a recognizable consumer-packaged-goods arc. Craft beer went through something similar in the 2010s: as the number of breweries multiplied and production scaled, per-unit pricing came under pressure even as total category volume kept climbing. Beverages appear to be entering that same phase -- more producers, more shelf competition, falling average price, rising unit volume.

Part of the appeal here is almost certainly occasion-based consumption. A beverage slots into rituals that already exist -- happy hour, dinner, a evening on the porch -- in a way flower and edibles generally don't. That's a plausible and intuitive driver of adoption, though it's worth being honest that POS data can show correlation between rising sales and expanding retail presence without cleanly isolating why any individual consumer picked up a can instead of a pre-roll.

Who's Actually Buying What: The Generational Split

Photo by lexphumirat via Pixabay.

Break the spending down by generation and the picture sharpens considerably. Millennials account for 42.8% of US cannabis spending -- the largest single bloc by a wide margin. Gen X follows at 23.5%, Gen Z at 21.2%, and Boomers at 12.6%. On its face, that's an unsurprising age-and-income distribution. What's more interesting is the trajectory: Gen Z's share climbed from 18.2% to 21.2% in just two years, making it the fastest-growing generational segment in the entire spending mix.

The format preference within that cohort is the real signal. Gen Z is the only generation whose top category isn't flower -- it's vapor pens. Every other generational bloc still defaults to flower as its leading purchase. That's a genuine divergence in baseline product preference, not just a difference in how much people spend.

There's a useful precedent for reasoning through this: the shift in younger tobacco and nicotine consumers toward vapes and nicotine pouches over cigarettes through the 2010s and into the 2020s. That generational move wasn't primarily about nicotine strength or cost -- it was about discretion, absence of persistent odor, and portability, and it was strongest among people who had no prior brand loyalty to cigarettes to begin with, because they'd never really smoked them. Gen Z cannabis consumers appear to be following a comparable logic: they're not converts away from flower so much as consumers who never built a flower habit as their default in the first place.

The dosing data reinforces that read rather than contradicting it. Forty-two percent of edible consumers now say they prefer 10mg of THC or less per serving -- a meaningfully moderate dose, especially set against the high-potency flower and concentrate products that dominated headlines through the 2010s. That's not the profile of consumers chasing maximum intoxication. It looks much more like a wellness- or moderation-oriented pattern, and it fits more naturally with younger and midlife consumers using cannabis functionally -- for sleep, stress, or a controlled social buzz -- than with legacy heavy users who built their habits around high-THC flower and concentrates. Put those two data points together and the generational story isn't just about who's spending more. It's about a genuinely different default relationship with the product.

What Canada's Head Start Tells Us About Where the US Is Going

Photo by Wendy Wei via Pexels.

Canada offers something the US market doesn't have yet: a full look at what happens several years after legalization, because Canada got there first. Recreational cannabis became legal there in October 2018, but the legislation itself built in a deliberate lag -- edibles, extracts, and topicals weren't legally permitted for retail sale until October 2019, a full year after flower hit shelves. That one-year gap wasn't a market outcome; it was a policy choice, and it shaped how the market's early structure formed.

Fast forward to now, and Health Canada's retail data shows dried flower's market share has contracted to roughly 48% of total unit sales. That's still a plurality -- flower remains the single largest category in Canada too -- but it's a long way down from cannabis's earliest years there, when flower was close to the entirety of the legal market by necessity, since nothing else was allowed to be sold yet.

The US is roughly a decade into broad legal retail in most states that have it, tracking a directionally similar path, but from a structurally different starting point. Canada built one national regulatory framework with a built-in product-category delay. The US built this market state by state, with no federal legalization at all and no uniform one-year gap between flower and other formats -- some states allowed edibles and vapes from day one of adult-use retail.

That difference makes the extrapolation genuinely reasoned rather than mechanical, but it's still a reasonable one to make: if the US continues along a broadly similar trajectory to Canada's, flower's current ~39% share could plausibly compress further toward the high-30s or low-30s over the next several years. How fast that happens depends heavily on two variables -- how individual state regulators choose to treat newer formats like beverages and infused pre-rolls, and how the federal hemp rule discussed next reshapes the competitive landscape around dispensary products. This is reasoned extrapolation built on a real historical parallel, not a forecast with a fixed date attached. Canada's smaller, more centralized regulatory system moved faster on some fronts and slower on others than the fragmented, 40-plus-state American system is likely to move, so the comparison is directional guidance, not a script.

The Hemp Rule That Could Wipe Out 95% of Beverage SKUs

Photo by Keegan Checks via Pexels.

Here's the fact that changes everything else in this piece: on November 12, 2025, Congress enacted Section 781 of P.L. 119-37, folded into the government funding package H.R. 5371. It's arguably the most consequential change to federal hemp policy since the 2018 Farm Bill first opened the loophole that let hemp-derived THC products proliferate outside the licensed cannabis system in the first place.

The rule takes effect November 12, 2026, and it replaces the old Delta-9 dry-weight percentage standard with something far stricter: a 0.4 milligram total THC cap per container for any finished hemp product, full stop -- gummies, tinctures, beverages, vapes, even hemp flower itself. That's not a per-serving cap in the way most consumer beverages are labeled; it's a hard ceiling on the entire container, which is a dramatically lower bar than most current hemp products are formulated to hit.

Industry estimates suggest roughly 95% of hemp drinks currently on shelves would fail to meet that standard as formulated today, meaning they'd need reformulation or removal from the market entirely by next November. That's not a rounding-error compliance issue -- it's close to the entire category.

This connects directly back to the beverage growth numbers from earlier in this piece. A significant share of that Michigan, Ohio, and broader BDSA-tracked beverage growth includes hemp-derived THC drinks sold entirely outside the state-licensed cannabis system, riding the 2018 Farm Bill's now-closing loophole rather than operating through state dispensary channels. If that supply gets squeezed out, the growth curve for beverages as a whole doesn't necessarily reverse -- but where that growth is coming from could shift dramatically.

There are pending legislative fixes in play, and none of them have resolved yet. The STATES 2.0 Act, the Hemp Access and Consumer Safety Act, and a proposed Cannabinoid Safety and Regulation Act carrying a 5mg-per-serving beverage cap are all sitting in front of a House Agriculture Committee that's simultaneously working toward a broader 2026 Farm Bill. The fair way to characterize all of this: it's a real, dated regulatory cliff, not speculation about a maybe-someday rule. But its ultimate market effect depends entirely on whether Congress amends that 0.4mg cap before November 2026 arrives -- something to track closely over the next several months, not something to confidently predict the outcome of either way.

Pull back and look at what's actually been established here versus what's projection. Three independent data sources -- Headset's POS tracking, BDSA's category breakdowns, and Health Canada's multi-year retail figures -- all point the same direction: flower remains the largest category everywhere it's measured, and its growth rate lags behind pre-rolls, infused formats, and beverages in market after market. That convergence across three separate datasets, built by three separate organizations tracking different geographies, is what makes this a real trend rather than a narrative stitched together from a few favorable anecdotes.

But the single biggest variable in where this goes over the next twelve months has nothing to do with what consumers actually want. It's whether Congress amends the 0.4 milligram THC container cap before it takes effect on November 12, 2026. Consumer preference has been trending toward convenience formats for years now, gradually and measurably. That trend doesn't need a policy assist to keep moving. What the hemp rule introduces is a discontinuity -- a hard deadline that could reshape which channel captures that demand, regardless of what consumers were already gravitating toward.

Here's the one thing worth actually watching in the coming year: the state-licensed beverage category specifically, as distinct from the hemp-derived drinks sold outside it. If Congress lets the 0.4mg cap stand and hemp beverages get squeezed off shelves, dispensary-based THC beverages don't need to win over new converts to gain share -- they inherit it by default, simply by being the compliant option left standing. That would mean a shift already underway for reasons of convenience and format preference gets accelerated by a completely unrelated regulatory mechanism. Two separate forces, pushing the same direction, for entirely different reasons. That's worth remembering the next time someone tries to explain this shift with a single, tidy cause.